Aberrantly expressed cytokeratin 1, a tumor-associated autoantigen in papillary thyroid carcinoma

International Journal of Cancer

Volumn 73, Issue 2, 1997, Pages 171-177

  Lucas, Steven D ^a   Ek, Bo ^b   Rask, Lars ^b   Rastad, Jonas ^a   Åkerström, Göran ^a   Juhlin, Claes ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CYTOKERATIN; TUMOR ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOLOGY; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGENICITY; MALE; METASTASIS; PAPILLARY CARCINOMA; PRIORITY JOURNAL; THYROID CARCINOMA;

AUTOANTIBODIES; AUTOANTIGENS; BLOTTING, WESTERN; CARCINOMA, PAPILLARY; CYTOSKELETON; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; KERATINS; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030806113     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971009)73:2<171::AID-IJC1>3.0.CO;2-T     Document Type: Article

References (22)

1. AEBERSOLD, P., HYATT, C., JOHNSON, S., MINES, K., KOKCAK, L., SANDERS. M., LOTZE, M., TOPALIAN, S., YANG. J. and ROSENBERG, S.A., Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response. J. nat. Cancer Inst., 83,932-937 (1991).
2. BAGNASCO, M., VENUTK D., PAOLIERI. F., TORRE, G., FERRINI, S. and CANONICA, G., Phenotypic and functional analysis at the clonal level of infiltrating T lymphocytes in papillary carcinoma of the thyroid: prevalence ot'cytotoxic T cells with natural killer-like or lymphokine activated killer activity. J. Cin. Enclocnnol Metab., 69, 832-836 (1989).
3. BAKER. J. and Fosso. C, Immunological aspects of cancers arising from thyroid follicular cells. Endocrine Rev., 14,729-746 (1993).
4. BULEY, I.D., GATTER, K.C., HERYET, A. and MASON. D.Y., Expression of intermediate filament proteins in normal and diseased thyroid glands. J. clin. Pathol., 40, 136-142(1987).
5. DAILY, M., LINDSAY, S., and SKAHEN, R., Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. Arch. Surg., 70,291-297 (1955).
6. GOLDSMITH, N., DIKMAN, S., BERMAS, B., DAVIES. T. and ROMAN. S., HLA class II antigen expression and the autoimmune thyroid response in patients with benign and malignant thyroid tumors. Clin. Immunol. Imnntnopathol., 48, 161-173(1988).
7. HENZEN, L.S., MULLINK, H., RAMAEKERS. F.C., TADRMA, T. and MEIJER. C.J., Expression of cytokeratins and vimentin in epithelial cells of normal and pathologic thyroid tissue. Virchows Arch. A. Pathol. Anat. Histopathowl., 410,347-354(1987).
8. HIRABAYASHI. R.N. and LINDSAY, S., The relation of thyroid carcinoma and chronic thyroiditis. Surg. Gynecol. Obstet., 121, 243-252 (1965).
9. KAMMA, H., FUJII, K. and OGATA, T., Lymphocytic infiltration in juvenile thyroid carcinoma. Cancer. 62,1988-1993 (1988).
10. KLYMKOWSKY, M.W., Intermediate filaments in 3T3 cells collapse after intracellular injection of a monoclonal anti-intermediate filament antibody. Nature (Lond.), 291, 249-251 (1981).
11. LIN, J.J. and FERAMISCO. J.R., Disruption of the in vivo distribution of the intermediate filaments in fibroblasts through the microinjection of a specific monoclonal antibody. Cell, 24,185-193 (1981).
12. LUCAS, S.D., EK, B., RASK, L., RASTAD, J., ÅKERSTRÖM, G., and JUHLIN, C., Identification of a 35 kD tumor-associated autoantigen in papillary thyroid carcinoma. Anticancer Res., 16, 2493-2496 (1996a).
13. LUCAS, S.D., KARLSSON-PARRA, A., NILSSON. B., GRIMELIUS. L., RASTAD, J., ÅKERSTRÖM. G. and JUHLIN, C., Tumor specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma. Hum. Pathol, 27, 1329-1335(1996b).
14. LUCAS-MARTIN, A., FOZ-SALA, M., TODD, I., BOTTAZZO, G. and PUJOL- BORRELL, R., Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies. J. Clin. Endocrinol. Metab., 66, 367-375 (1988).
15. NIEDOBITEK G., FAHRAEUS, R., HERBST, H., LATZA, U., FERSZT, A., KLEIN, G, and STEIN, H., The Epstein-Barr virus encoded membrane protein (LMP) induces phenotypic changes in epithelial cells. Virchows Arch. B. Cell. Pathol. Incl. Mol.Pathol., 62,55-59 (1992).
16. PARDOLL, D.M., Genetically engineered tumor vaccines. Ann. N.Y. Acad. Sci., 690,301-310(1993).
17. ROSENBERG, S., PACKARD, B, and AEBERSOLD, P., Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N. Engl J. Med., 319, 1676-1680(1988).
18. SAMAAN, N.A., SCHULTZ. P.N., MICKEY. R.C., GOEPFERT. H., HAYNIE, T., JOHNSON, D.A. and ORDONEZ. N.G., The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J. clin. Endocrinol. Metab., 75,714-720(1992).
19. TOH, B.H., Anti-cytoskeletal autoantibodies: diagnostic significance for liver diseases, infections and systemic autoimmune diseases. Autoiminunity, 11,119-125(1991).
20. TOPALIAN, S.L., MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy. Curr. Opin. Immunol., 6, 741-745 (1994).
21. VANKY, F. and KLEIN, E., Requirement of MHC class I antigen expression on human tumors for in vitro recognition by autologous blood lymphocytes. Semin. Cancer Biol., 2,55-62 (1991).
22. WIRTH, P.J., Luo, L.D., FUJIMOTO. Y. and BISCAARD. H.C., Epidermal growth factor receptor ligands regulate keratin 8 expression in keratinocytes. and transforming growth factor alpha mediates the induction of keratin 8 by the V-rasHa oncogene. Cell. Growth Differ., 4,317-327 (1993).